ZymoGenetics

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection Hepatitis C, Chronic	Phase 2	2010-05-01
Completed	Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants Blood Loss, Surgical	Phase 4	2009-03-01
Completed	Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis Blood Loss, Surgical	Phase 4	2009-01-01
Completed	Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection Hepatitis C, Chronic	Phase 1	2007-12-01
Completed	Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis Spinal Surgery, Vascular Surgery	Phase 3	2007-06-01
Completed	Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma Carcinoma, Renal Cell	Phase 1 / Phase 2	2006-10-01
Completed	Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting Surgical Hemostasis	Phase 2	2006-08-01
Completed	Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin	Phase 1	2006-06-01
Completed	Study of Recombinant Human Thrombin for Bleeding During Surgery Surgical Hemostasis	Phase 3	2005-10-01
Completed	Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer Melanoma, Kidney Neoplasms, Metastases	Phase 1	2004-05-01